Ozgur, G.K.Aydin, S.K.Mammadov, R.Kahraman, U.Ekren, P.K.Ozdil, A.Cagirici, U.2024-08-252024-08-2520230041-1345https://doi.org/10.1016/j.transproceed.2023.03.035https://hdl.handle.net/11454/100148Pulmonary complications may occur after hematopoietic stem cell transplantation for hematologic malignancies. Lung transplantation is the only treatment option for end-stage lung failure. We presented a case of acute myeloid leukemia who received a hematopoietic stem cell transplantation and underwent bilateral lung transplantation with end-stage usual interstitial pneumonia and chronic obstructive lung disease. This case showed that lung transplantation could be successfully applied in properly selected hematologic malignancy patients with long disease-free survival, like lung transplantations performed for other indications. © 2023 Elsevier Inc.en10.1016/j.transproceed.2023.03.035info:eu-repo/semantics/closedAccessArticle2-s2.0-85154615254Q3